Morgan Stanley (MS)
173.72
+4.63 (2.74%)
NYSE · Last Trade: Dec 4th, 3:31 AM EST
Shares of cosmetics company e.l.f. Beauty (NYSE:ELF)
jumped 6.2% in the afternoon session after the company presented at the Morgan Stanley Global Consumer & Retail Conference. Such investor conferences are important events where company leaders often share updates on their business strategy, financial performance, and future outlook. A positive presentation can increase investor confidence and drive interest in a company's stock. The significant upward move in the share price suggested that the market reacted favorably to the information and commentary provided by e.l.f. Beauty's management team during the event.
Via StockStory · December 3, 2025
Shares of toy manufacturing and entertainment company (NASDAQ:MAT)
jumped 4.8% in the afternoon session after the company presented at the Morgan Stanley Global Consumer & Retail Conference, where its leadership shared business updates.
Via StockStory · December 3, 2025
Shares of material handling equipment manufacturer Columbus McKinnon (NASDAQ:CMCO)
jumped 3.4% in the afternoon session after the company presented at a Bank of America conference, highlighting its strong market position and growth prospects. The presentation detailed the company's expansion into high-growth areas like automation and linear motion. Columbus McKinnon pointed to a total addressable market of $34 billion. Management also noted that its growth was supported by major industry trends, including labor shortages and electrification. These factors are driving demand for the company's lifting and automation solutions, which help customers handle critical materials. The positive outlook likely boosted investor confidence.
Via StockStory · December 3, 2025
Shares of diagnostics company Guardant Health (NASDAQ:GH)
jumped 1.8% in the afternoon session after Morgan Stanley raised its price target on the stock, reflecting heightened optimism about the company's potential. The firm's analyst, Shannon O’Callaghan, maintained an "Overweight" rating on Guardant Health while increasing the price target to $130.00 from $105.00. This action followed other positive price target adjustments from analysts in the recent past. Specifically, both BTIG and Canaccord Genuity also previously increased their price targets for the company. These collective revisions signaled a growing positive view of the stock among financial analysts.
Via StockStory · December 3, 2025
Shares of building products company Quanex (NYSE:NX)
jumped 3.8% in the afternoon session after positive technical signals and investor optimism about future earnings growth outweighed mixed historical data.
Via StockStory · December 3, 2025
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM)
jumped 4.5% in the afternoon session after an analyst at Morgan Stanley raised the firm's price target for the stock. The firm's analyst, Patrick Wood, kept an 'Equal-Weight' rating on Tandem Diabetes Care but increased the price target by over 35%, moving it from $17.00 to $23.00. This adjustment suggested a more positive outlook on the stock's value, even while the overall rating remained neutral. The action indicated that the analyst saw more potential upside for the company's shares than previously estimated.
Via StockStory · December 3, 2025
Shares of energy drink company Celsius (NASDAQ:CELH)
jumped 3.6% in the afternoon session after the company provided a positive business update ahead of a conference, highlighting strong market share growth and progress on integrating its Alani Nu brand with its PepsiCo distribution partner.
Via StockStory · December 3, 2025
Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX)
jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and increased its price target. The new price target was set at $516, a notable increase from the previous $438. The upgrade reflected the bank's more positive outlook on the potential within Vertex's kidney drug pipeline. The firm specifically highlighted two drug candidates, Pove and Inaxaplin, as key drivers for this optimism. This positive view was formed ahead of the expected release of Phase 3 clinical trial data for these drugs in 2026, suggesting strong confidence in the company's future prospects.
Via StockStory · December 3, 2025
Shares of battery and lighting company Energizer (NYSE:ENR)
jumped 7.6% in the afternoon session after the stock appeared to rebound from a 52-week low set in the prior session, a drop that followed several analyst price target cuts.
Via StockStory · December 3, 2025
New York, NY – December 3, 2025 – In a significant move reverberating through the biotechnology sector, investment banking giant Morgan Stanley has downgraded Regeneron Pharmaceuticals (NASDAQ: REGN) from "Overweight" to "Equal-Weight." The firm maintained its price target of $767.00, signaling that, in their view, the stock is now fairly valued
Via MarketMinute · December 3, 2025
NEW YORK, NY – December 3, 2025 – Morgan Stanley (NYSE: MS) has today achieved a significant milestone, with its stock price reaching an all-time high of $171.78. This landmark achievement underscores the financial services giant's exceptional performance and robust strategic positioning in a dynamic global market. The surge reflects strong
Via MarketMinute · December 3, 2025
Valued at a market cap of $1.8 trillion, Broadcom is a mega-cap chip stock that offers significant upside potential, according to Morgan Stanley.
Via Barchart.com · December 3, 2025
Nvidia stock is at the epicenter of the AI gold rush and has significant upside potential in December 2025, according to Morgan Stanley.
Via Barchart.com · December 3, 2025
In a significant move that has captured the attention of financial markets, Deutsche Bank (DB) (NYSE:DB) has issued an exceptionally bullish forecast for the S&P 500 (SPX) (NYSEARCA:SPY), setting a year-end target of 8,000 for 2026. This ambitious prediction positions Deutsche Bank's outlook as one of
Via MarketMinute · December 3, 2025
Shares of analog chips maker onsemi (NASDAQ:ON)
jumped 7.1% in the morning session after the company announced plans to collaborate with Innoscience to speed up the global rollout of its Gallium Nitride (GaN) power portfolio.
Via StockStory · December 3, 2025
Check out the companies making headlines yesterday:
Via StockStory · December 3, 2025
Both AI giants might launch their public market offerings next year.
Via Stocktwits · December 3, 2025
Despite AutoZone’s recent underperformance relative to the Nasdaq, analysts remain highly optimistic about the stock’s prospects.
Via Barchart.com · December 3, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Charles Schwab (NYSE:SCHW) and its peers.
Via StockStory · December 2, 2025
Shares of semiconductor machinery manufacturer Applied Materials (NASDAQ:AMAT)
jumped 4.4% in the afternoon session after several investment firms expressed a positive outlook for the company, with KeyBanc and Morgan Stanley raising their price targets and UBS upgrading the stock's rating. KeyBanc increased its price target to $285 from $240, keeping an Overweight rating. The firm noted long-term demand drivers from artificial intelligence applications. In a similar move, UBS upgraded Applied Materials from Neutral to Buy and also set a $285 price target, citing a good outlook for wafer fab equipment, which is used to produce memory chips. Adding to the positive sentiment, Morgan Stanley adjusted its price target upward to $273 from $252, while also maintaining an Overweight rating on the shares.
Via StockStory · December 2, 2025
As 2025 draws to a close, Wall Street's leading analysts are largely painting a robust and optimistic picture for the stock market in the coming year, 2026. The prevailing sentiment is that the current bull market, significantly fueled by the transformative power of Artificial Intelligence (AI), is set to continue
Via MarketMinute · December 2, 2025
As global financial markets continue to grapple with an unprecedented confluence of persistent inflation, escalating geopolitical tensions, and the intricate dance of central bank interest rate policies, investors find themselves at a critical juncture. The allure of "market timing"—the tantalizing prospect of perfectly predicting market peaks and troughs—often
Via MarketMinute · December 2, 2025
Shares of search AI platform provider Elastic (NYSE:ESTC) jumped 2.3% in the afternoon session after the company announced a strategic investment in investigations software firm Siren.
Via StockStory · December 2, 2025
Shares of auto parts and accessories retailer AutoZone (NYSE:AZO)
fell 2.7% in the afternoon session after a Morgan Stanley report highlighted potential headwinds for the company, including tariffs and increased investments in business operations. The investment bank pointed to tariffs, which are taxes on imported goods, as a potential factor that could increase costs. The report also noted that AutoZone's own investments in selling, general, and administrative expenses—the day-to-day costs of running the business—could create challenges. Despite these concerns, the analysis acknowledged that the company could still see benefits from favorable long-term trends within the auto parts industry.
Via StockStory · December 2, 2025
Shares of semiconductor quality control company Nova (NASDAQ:NVMI) jumped 4.2% in the morning session after Morgan Stanley initiated coverage on the stock with an "Equalweight" rating and a $335 price target. While an "Equalweight" rating suggests the stock is expected to perform in line with the average stock in the analyst's coverage universe, the initiation of coverage itself brought new attention to the company. The move also came amid a broader rebound for technology stocks. Sentiment in the sector was lifted by continued optimism surrounding Artificial Intelligence (AI) development, which helped push shares of large tech companies higher. Further boosting the industry, NVIDIA disclosed a significant investment in Synopsys, another company in the semiconductor space, signaling strong investor confidence in the sector.
Via StockStory · December 2, 2025